Aptyx Promotes CFO David Price to CEO

Contract development and manufacturing organization (CDMO) Aptyx has appointed David Price as its new CEO, effective immediately.

Price has been the company’s chief financial officer (CFO) since joining Aptyx last year. The company said he brought a strong combination of financial discipline, operational and commercial focus, and strategic insight.

In that role, he helped sharpen Aptyx’s priorities, strengthen execution, and position the company for its next growth stage.

As CEO, Price will focus on speeding growth, deepening customer partnerships, developing leadership capabilities, and bolstering the company’s role as a partner to medical device companies across the world.

Comments from Aptyx and TruArc

David Price, incoming CEO: “I am honored to lead Aptyx at such an important stage in our growth. We operate in a dynamic medical device market with significant opportunities ahead. With our talented team, technical capabilities, customer-centric culture, and commitment to the highest quality standards, Aptyx is well positioned to deliver innovative solutions and create long-term value for our employees, customers, and stakeholders.”

John Pless, co-managing partner, financial backer TruArc: “David has earned the confidence of the Board through his leadership, business acumen, and clear commitment to our customers, employees, and growth strategy. He is the right leader to build on Aptyx’s strong foundation and accelerate the company’s continued growth.”